Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis-Reference-Cited by-同舟云学术

Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis

Author:

Chang Ming-Chu¹,Jan I-Shiow²,Liang Po-Chin³,Jeng Yung-Ming⁴,Yang Ching-Yao⁵,Tien Yu-Wen⁵,Wong Jau-Min¹,Chang Yu-Ting¹

Affiliation:

1. Department of Internal Medicine; National Taiwan University Hospital; College of Medicine; National Taiwan University; Taipei Taiwan

2. Department of Laboratory Medicine; National Taiwan University Hospital; College of Medicine; National Taiwan University; Taipei Taiwan

3. Department of Medical Image; National Taiwan University Hospital; College of Medicine; National Taiwan University; Taipei Taiwan

4. Department of Pathology; National Taiwan University Hospital; College of Medicine; National Taiwan University; Taipei Taiwan

5. Department of Surgery; National Taiwan University Hospital; College of Medicine; National Taiwan University; Taipei Taiwan

Funder

National Science Council, Taiwan

National Taiwan University Hospital

Liver Disease Prevention & Treatment Research Foundation

New Century Health Care Promotion Foundation

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

Reference30 articles.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献